Stevanato Group SpA at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript

Mar 22, 2022 / 01:00PM GMT
Paul Knight - KeyBanc Capital Markets - Analyst

Good morning. This is Paul Knight, the life science analyst at KeyBanc. It's a pleasure to have today the management team from Stevanato Group. With us today is Franco Stevanato, the Chairman of the company; Franco Moro, the CEO; and Marco Dal Lago, Chief Financial Officer; and Lisa Miles, who is Head of Investor Relations. (Conference Instructions)

Questions and Answers:

Paul Knight - KeyBanc Capital Markets - Analyst

So with that, I guess I would start out with the first question for you, Franco Stevanato, and that is if you could kind of do the history of the firm and where you sit relative to the names that I think other investors are familiar, specifically West and SCHOTT and Becton Dickinson.

Franco Stevanato - Stevanato Group SpA - Chairman

Sure, Paul. Thank you very much. So first of all, good morning, everybody. Stevanato Group is a company that have a special legacy that was founded in 1949. It's a company that, since the end of 1980, we focused all our
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot